has been cited by the following article(s):
|
[1]
|
TIMELINE MANAGEMENT STRATEGIES: ENABLING DEVELOPING COUNTRIES TO DELIVER COMPLEX GENERICS TO GLOBAL MARKETS
International Journal of Applied Pharmaceutics,
2026
DOI:10.22159/ijap.2026v18i1.53438
|
|
|
|
|
[2]
|
Exploring Additional Strength Biowaiver Perspectives in the ICH M13B Framework for Immediate Release Solid Oral Dosage Forms: Opportunities & Challenges
Therapeutic Innovation & Regulatory Science,
2026
DOI:10.1007/s43441-025-00900-0
|
|
|
|
|
[3]
|
Q1 and Q2 selection, Q3, IVRT, IVPT, pharmacokinetic and pharmacodynamic evaluation of topical generic product
Drug Development and Industrial Pharmacy,
2025
DOI:10.1080/03639045.2025.2486487
|
|
|
|
|
[4]
|
The Global Pharmaceutical Trade Network: Spatiotemporal Evolution, Driving Forces, and China’s Evolving Role
Applied Spatial Analysis and Policy,
2025
DOI:10.1007/s12061-025-09706-x
|
|
|
|
|
[5]
|
Safety of reproduced pharmaceuticals and legal issues of their circulation in Russia
RUDN Journal of Law,
2024
DOI:10.22363/2313-2337-2024-28-4-875-891
|
|
|
|